WHO ICTRP trial
Study for safety of Betadine Throat Spray with Standard care of therapy
CTRI/2024/01/061247 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2024/01/061247 |
|---|---|
| Public title | Study for safety of Betadine Throat Spray with Standard care of therapy |
| Scientific title | A Phase-III multi centre, randomized, parallel, double blind, placebo control, clinical study to determine the efficacy and safety of Betadine PVPI-0.45 % weight per volume throat spray, applied along with standard of care therapy in patients suffering from Tonsillitis and Pharyngitis (throat… |
| Primary sponsor | GS Pharmbutor Private Limited |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: J039- Acute tonsillitis, unspecified |
| Interventions | Intervention1: Betadine PVPI-0.45 percentage weight per volume Throat Spray : Dose-0.45 percentage weight per volume Throat Spray Frequency- One or two spray, 3-4 times a day Duration- 5 days Control Intervention1: Placebo Throat Spray… |
| Registration date | Sep 1, 2024 |
| Target size | 192 |
| Secondary IDs | CT-CE-TS-2022 Version 1.0 dated 19 Sept 2022 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: